Source: EnWave Corporation
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • EnWave Corporation (ENW) has signed a material transfer agreement with MedImmune Limited, an affiliate of AstraZeneca
  • The companies plan to perform trials on EnWave’s Radiant Energy Vacuum (REV) technology, testing the dehydration of liquid monoclonal antibody formulations
  • AstraZeneca will send its proprietary materials to EnWave’s testing facility in Vancouver to conduct initial proof-of-concept trials
  • EnWave Corporation is a Vancouver-based advanced technology company
  • EnWave Corporation (ENW) is up 1.00 per cent on the day, trading at $1.01 per share

EnWave Corporation (ENW) has signed a material transfer agreement with MedImmune Limited, an affiliate of AstraZeneca AB.

Based in the United Kingdom, AstraZeneca AB is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines.

The company focuses on oncology and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology medicines.

The companies will use the material transfer agreement to perform trials on EnWave’s Radiant Energy Vacuum (REV) technology, testing the dehydration of liquid monoclonal antibody formulations.

The REV technology is an innovative, proprietary method for the precise dehydration of organic materials. EnWave has demonstrated REV technology’s commercial viability and is growing its use across several market verticals in the food, cannabis, and pharmaceutical sectors.

According to EnWave, “REV technology allows for rapid, gentle drying allows the active components of vaccines to remain alive but also allows for extreme precision over the final moisture content enabling a long shelf life.”

AstraZeneca will send its proprietary materials to EnWave’s testing facility in Vancouver to conduct initial proof-of-concept trials.

If the trials are successful, the two companies intend to negotiate a more in-depth agreement to facilitate further research and development activities.

EnWave Corporation is a Vancouver-based advanced technology company.

EnWave Corporation (ENW) is up 1.00 per cent on the day, trading at $1.01 per share as of 3:04 pm ET.

More From The Market Herald

" Mobi724 (TSXV:MOS) signs a long-term agreement with CGI

Mobi724 (MOS) has signed a long-term license and support agreement with independent IT and business consulting services firm CGI (TSX:GIB.A).
Datametrex - CEO, Marshall Gunter.

" Datametrex’s (TSXV:DM) Medi-Call app hits Vancouver market

Datametrex’s (DM) Medi-Call app is now available for Android users in Vancouver.

" Turnium Technology (TSXV:TTGI) appoints two new board members

Turnium Technology Group (TTGI) has appointed Evelyn Bailey and Peter Green to its Board of Directors.
FansUnite - CEO, Scott Burton.

" FansUnite Entertainment (CSE:FANS) granted conditional approval to list on TSX

FansUnite (FANS) has announced its conditional approval to list on the TSX.